MetaVia Inc. (MTVA) Insider Trading Disclosures
MetaVia Inc. (MTVA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MTVA
CIK: 1638287
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerDean Drummond
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-12 | OWNERSHIP DOCUMENT | 0001104659-26-115494 | View SEC Doc Filr Page |
| 3 | 2026-10-13 | 2026-10-12 | OWNERSHIP DOCUMENT | 0001104659-26-115491 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-13 | 8-K | 0001104659-26-115300 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001104659-26-106156 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-092051 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001104659-26-091981 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-09 | FORM 8-K | 0001104659-26-082116 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | FORM 8-K | 0001104659-26-080316 | View SEC Doc Filr Page |
| 424B5 | 2026-07-02 | — | 424B5 | 0001104659-26-080305 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-08 | OWNERSHIP DOCUMENT | 0001104659-26-071475 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-08 | OWNERSHIP DOCUMENT | 0001104659-26-071474 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-08 | OWNERSHIP DOCUMENT | 0001104659-26-071473 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-08 | OWNERSHIP DOCUMENT | 0001104659-26-071472 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-08 | OWNERSHIP DOCUMENT | 0001104659-26-071471 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-08 | OWNERSHIP DOCUMENT | 0001104659-26-071469 | View SEC Doc Filr Page |
| S-8 | 2026-06-08 | — | FORM S-8 | 0001104659-26-071406 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | FORM 8-K | 0001104659-26-071358 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | 8-K | 0001104659-26-071211 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | 8-K | 0001104659-26-066631 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | 8-K | 0001104659-26-063059 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002373 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001104659-26-061166 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001104659-26-061148 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001104659-26-058332 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001140361-26-016808 | View SEC Doc Filr Page |